Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23997016

Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2014 Feb
First author
Anderson PM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Anderson PM
      type
      Author
    2. name
      Meyers P
      type
      Author
    3. name
      Kleinerman E
      type
      Author
    4. name
      Venkatakrishnan K
      type
      Author
    5. name
      Hughes DP
      type
      Author
    6. name
      Herzog C
      type
      Author
    7. name
      Huh W
      type
      Author
    8. name
      Sutphin R
      type
      Author
    9. name
      Vyas YM
      type
      Author
    10. name
      Shen V
      type
      Author
    11. name
      Warwick A
      type
      Author
    12. name
      Yeager N
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Anderson PM
      type
      Author
    2. name
      Meyers P
      type
      Author
    3. name
      Kleinerman E
      type
      Author
    4. name
      Venkatakrishnan K
      type
      Author
    5. name
      Hughes DP
      type
      Author
    6. name
      Herzog C
      type
      Author
    7. name
      Huh W
      type
      Author
    8. name
      Sutphin R
      type
      Author
    9. name
      Vyas YM
      type
      Author
    10. name
      Shen V
      type
      Author
    11. name
      Warwick A
      type
      Author
    12. name
      Yeager N
      type
      Author
    bibliography ids
    1. nci-bib-30ac9b62b112fd693f0b6ed3
    book metadata
    content sha256
    063a61ed9ee456f735cee7b6fd5d9e887c4589a6bcbf859d63d9238b3589e6c2
    document type
    citation
    dois
    1. 10.1002/pbc.24686
    electronic publication date
    display
    2013 Aug 31
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23997016
    immutable id
    pubmed:23997016@063a61ed9ee456f735cee7b6fd5d9e887c4589a6bcbf859d63d9238b3589e6c2
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    2
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    238-44
    volume
    61
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23997016
      provenance
      batch id
      0a08f044391426feb8ef
      provider
      NCBI PubMed ESummary
      record sha256
      69f0003bc9ebde367a03e1f564e2f45888dc380c01d2155f00b9fd43a13f8a12
      response sha256
      d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
      retrieved at
      2026-09-09T23:46:57.614689+00:00
      publication date
      display
      2014 Feb
      precision
      month
      year
      2014
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23997016/
      title
      Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.

      Preserved source evidence · Not medical advice